Table 2 Association of IL-38 serum levels (pg/ml) with the demographic and clinical outcomes of the asthmatic groups
From: Serum interleukin 38 (IL-38) as a new potential biomarker of pediatric asthma
Asthmatic patients (n=73) | p-value | Atopic patients (n=34) | p-value | Non-atopic patients (n=39) | p-value | |
|---|---|---|---|---|---|---|
Sex | ||||||
Males | 481 (418–660) | 0.855 | 456 (416–714) | 0.408 | 509 (425–638) | 0.461 |
Females | 516 (407–614) | 493 (363–552) | 557 (421–733) | |||
Exacerbation | ||||||
Seasonal | 505 (415–651) | 0.316 | 505 (370–623) | 0.705 | 528 (435–706) | 0.356 |
Perennial | 472 (404–598) | 434 (412–546) | 510 (367–601) | |||
Asthma control | ||||||
Poor | 477 (409–629) | 0.530 | 436 (364–607) | 0.408 | 527 (435–660) | 0.933 |
Good | 512 (412–635) | 514 (420–625) | 509 (410–703) | |||
Eosinophilic asthma | ||||||
Present | 468 (401–584) | 0.011 | 425 (370–525) | 0.012 | 495 (410–606) | 0.290 |
Absent | 616 (477–715) | 620 (526–778) | 615 (454–749) | |||